3rd mRNA-Based Therapeutics Summit Europe

The 3rd mRNA-Based Therapeutics Summit Europe covers topics such as:

• Clinical Updates to Accelerate the Next Wave of mRNA Vaccines for Infectious Diseases & Oncology
• Novel RNA Technology Approaches to Expand Vaccine & Therapeutic Application
• Translating CMC Methods to Advance mRNA Products from Bench to Clinic with Ease
• Translating Preclinical to Clinical Success in the Context of mRNA-Based Therapeutics & Vaccines
• Unravelling mRNA-Delivery Thermostability to Produce Best-In-Class Drug Formulations
• Delving into Novel Applications of mRNA-Based Therapeutics to Expand Potential Beyond Infectious Diseases
• Clinical Updates to Accelerate the Next Wave of mRNA Vaccines for Infectious Diseases & Oncology
• Unlocking Novel RNA Technology Approaches to Expand Vaccine & Therapeutic Application
• Translating CMC Methods to Advance mRNA Products from Bench to Clinic with Ease
• Translating Preclinical to Clinical Success in the Context of mRNA-Based Therapeutics & Vaccines
• Unravelling mRNA-Delivery Thermostability to Produce Best-In-Class Drug Formulations
• Tech Slam
• Delving into Novel Applications of mRNA-Based Therapeutics to Expand Potential Beyond Infectious Diseases
• Driving the Vision of the European mRNA Regulatory Landscape for First-in-Class mRNA Therapeutics & Emerging Health Threats
• Developing Next Generation Delivery Vehicles to Improve Translational Potential
• Strategising Analytical Development Considerations from mRNA Drug Substance to Drug Products
• Achieving Effective Cell & Tissue Specificity in vivo for Next Generation mRNA-Based Therapeutics
• Overcoming mRNA Quality Control Considerations to Ensure Biological Efficacy of mRNA Candidates
• Unlocking Diseases of Tomorrow with Disruptive Companies & Next-Generation RNA Therapeutics